Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
Yngvar Lunde HaaskjoldNjål Gjærde LuraRune BjørneklettLeif BostadLars Sigurd BostadThomas KnoopPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
We have externally validated two prediction tools for IgA nephropathy. The International IgAN Prediction Tool performed well, while the IgA Nephropathy Clinical Decision Support System has some limitations.